New Subtype of Depression Linked to Body Clock Disruption, Study Suggests

Scientists have identified a potential subtype of depression, termed 'circadian depression,' which may affect individuals whose symptoms are linked to disrupted sleep and wakefulness patterns. This condition could explain why a significant portion of patients do not respond to conventional antidepressant medications.

The findings, published in the British Journal of Psychiatry, are based on data from over 11,000 participants in the Australian Genetics of Depression Study. Researchers identified nearly 25 percent, or 2,604 individuals, as exhibiting characteristics of circadian depression.

This subtype is reportedly marked by seasonal illness patterns, excessive sleep during depressive episodes, persistent fatigue, and a tendency to be more active at night. Patients identified with circadian depression were also found to be more prone to developing the condition at a younger age and experiencing more severe symptoms, including mania and suicidal thoughts.

Genetic analysis further suggested an increased risk of heart disease, inflammatory conditions, and neurodevelopmental disorders such as ADHD among individuals with this subtype. "Depression is not a uniform illness and understanding the characteristics of different subtypes means we can give people earlier access to treatments that will be most effective for them," said Dr. Emiliana Tonini, lead author and mental health researcher at the University of Sydney.

Researchers propose that treatments targeting the circadian rhythm, such as light therapy and melatonin, could be more effective for these patients. Melatonin, a hormone naturally produced in response to darkness, helps regulate the body's sleep-wake cycle. Synthetic forms of melatonin and light therapy are suggested as beneficial for restoring disrupted sleep patterns.

"Because circadian depression is linked to people's internal body clock, treatments targeting the circadian rhythm, such as light therapy and melatonin, may be much more relevant and should be used much earlier in these patients," stated study co-author Dr. Jacob Crouse. "For those who find that antidepressants are not working for them, it is important to speak to your clinician for advice about your individual circumstances."

Professor Ian Hickie, a clinical psychiatrist at Sydney University's Brain and Mind Centre, emphasized the importance of recognizing circadian depression in young people, noting that alternative circadian-focused medical and behavioral options may be more effective than SSRIs for a substantial portion of this demographic.

However, some experts have expressed reservations. Professor David Curtis of University College London commented that the findings might not constitute a distinct subtype, as typical depression features can include circadian elements. He also suggested the term 'circadian' might be misleading. Other researchers noted that while the findings may not immediately alter prescribing practices, they underscore the significance of evaluating sleep-wake patterns in mood disorders.